USFDA gives tentative nod to Alembic Pharma for Ivabradine tablets

Ivabradine tablets are indicated to reduce the risk of hospitalization for worsening heart failure

257
USFDA Approval
USFDA Approval

Last Updated on October 15, 2024 by The Health Master

Alembic Pharma announced that it has received tentative approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Ivabradine tablets, 5 mg and 7.5 mg.

The tentatively approved ANDA is therapeutically equivalent to the Reference Listed Drug (RLD) product Corlanor tablets, 5 mg and 7.5 mg, of Amgen, Alembic Pharma notified in a statement.

Ivabradine tablets are indicated to reduce the risk of hospitalization for worsening heart failure in adult patients with stable, symptomatic chronic heart failure with left ventricular ejection fraction ≤ 35 per cent, who are in sinus rhythm with resting heart rate ≥ 70 beats per minute and either are on maximally tolerated doses of beta-blockers or have a contraindication to beta-blocker use.

Ivabradine tablets are indicated for the treatment of stable symptomatic heart failure due to dilated cardiomyopathy (DCM) in pediatric patients aged six months and older, who are in sinus rhythm with an elevated heart rate.

It may not be indicated for certain other uses due to unexpired exclusivities for the RLD for such uses, the statement added.

USFDA gives nod to Lupin for Desvenlafaxine ER tablets

USFDA authorises first C-19 diagnostic test using breath samples

USFDA gives approval to Aleor for Lidocaine & Prilocaine cream

USFDA gives nod to Indoco Remedies for Lacosamide injection

USFDA gives tentative approval to Alembic for generic Pradaxa capsules

USFDA approves Cell Therapy for earlier lymphoma

AIDCOC has represented to MPSC to revise the education qualification advertised for the post of Assistant Commissioner

IPGA in association with DCO INDIA DRUGS CONTROL FORUM organized an International Webinar on DESIGNER DRUGS

NPPA expert panel decides not to fix ceiling price of Clotrimazole…

NPPA fixes Retail Price of 15 formulations: April 2022

USFDA gives nod to Lupin for Desvenlafaxine ER tablets

Drug recall: Insulin Glargine recalled due to this reason

DCGI: Fourfold increase in Investigational New Drugs Applications in India

4 Medical Devices Parks to come up in a total of 1,326 acres

CDSCO Committee gives approval to Sun Pharma for Ranibizumab

Latest Notifications regarding Pharmaceuticals

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news